Radical Curative Activity of a New 8-Aminoquinoline Derivative (CDRI 80/53) against Plasmodium cynomolgi B in Monkeys

G. P. Dutta Division of Microbiology and Medicinal Chemistry, Central Drug Research Institute, Lucknow, India

Search for other papers by G. P. Dutta in
Current site
Google Scholar
PubMed Close
,
S. K. Puri Division of Microbiology and Medicinal Chemistry, Central Drug Research Institute, Lucknow, India

Search for other papers by S. K. Puri in
Current site
Google Scholar
PubMed Close
,
A. P. Bhaduri Division of Microbiology and Medicinal Chemistry, Central Drug Research Institute, Lucknow, India

Search for other papers by A. P. Bhaduri in
Current site
Google Scholar
PubMed Close
, and
Manju Seth Division of Microbiology and Medicinal Chemistry, Central Drug Research Institute, Lucknow, India

Search for other papers by Manju Seth in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1989.41.635
Volume/Issue:
Volume 41: Issue 6
Page(s):
635–637
Restricted access
Get Permissions

An analogue of primaquine, N1-(3-acetyl-4-5-dihydro-2-furanyl)-N4-(6-methoxy-8-quinolinyl) 1, 4-pentanediamine, CDRI Code 80/53), has been evaluated for anti-relapse activity against sporozoite induced Plasmodium cynomolgi B infection in rhesus monkeys. The compound has shown 100% curative anti-relapse activity at 1.25 mg/kg × 7 day dose schedule, thereby giving a primaquine index of 0.8. The compound is currently under Phase-I clinical trials.
Copyright:
Copyright © 1989 by The American Society of Tropical Medicine and Hygiene 1989
Published Online:
Dec 1989
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 358 145 4
Full Text Views 4 0 0
PDF Downloads 2 0 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save